As shown in Figure 6, there were 4 common mutation sites between tissue and ctDNA samples before treatment (S145 and S124), affecting four known tumor-related genes CREBBP, ROS1, TP53 and EGFR, which might help with the selection of treatment options. This evidence concerns the gene CREBBP and neoplasm.